Specializing in targeted anti-cancer drugs, Nanjing Ange Pharmaceutical Co. engages in the research, development and manufacturing of APIs and intermediates. We have two manufacturing plants, a GMP-certified plant at Yanjia Chemical Park, Chongqing and another plant in Jiande, Hangzhou, which has passed ISO9001, ISO14001 and OHSAS18001. The Chinese FDA has inspected and approved both, while the American FDA has done so for the Hangzhou plant. Many domestic and foreign clients have done their own inspections and approved our facilities.

Since establishing our company in 2003, we have been focusing on anti-cancer drugs such as Ceritinib, Lenvatinib, Afatinib and others. We have become a top supplier in this category with one of the most complete product offerings. Having exported to 7 different countries, we constantly strive to perfect our product quality while lowering costs.

Nanjing Ange looks forward to building long-term partnerships with companies around the world.